Clinical Trial Update: Validation of a Quality of Life Metric "Prolac-10"

View source ↗

Summary

The study validating the Prolac-10 quality-of-life metric for prolactin-producing pituitary tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma
• Prolactin-producing Pituitary Tumor
• Prolactinoma

Snippet

Sponsor: Ohio State University | Conditions: Prolactinoma, Prolactin-Producing Pituitary Tumor | Status: TERMINATED